Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stryker Corporation (SYK)
NYSE:SYK
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
2.74Last Year’s EPS
2.5Same Quarter Last Year
Strong Buy
Based on 22 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Jan 28, 2025
|% Change Since: -2.21%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
The earnings call reflected strong performance and growth across multiple segments, driven by successful product launches and strategic acquisitions. Despite challenges in the Spinal Implants business and foreign currency impacts, the company's robust operating margin expansion and high growth in key areas suggest positive momentum going into 2025.Company Guidance
During the fourth quarter 2024 earnings call, Stryker provided comprehensive guidance, projecting an 8% to 9% organic sales growth for 2025, reflecting the high end of the med tech sector. This growth, coupled with continued operating margin expansion, translates to an adjusted EPS forecast between $13.45 and $13.70, excluding the impacts of the Inari acquisition. The company exceeded its adjusted operating margin goals for 2024, achieving a 200 basis point improvement in Q4 and 110 basis points for the full year. Earnings highlighted a quarterly and full-year adjusted EPS growth of 16% and 15%, respectively. Stryker also announced the sale of its Spinal Implants business to focus resources better and capitalize on high-growth markets, while maintaining enthusiasm for Interventional Spine and enabling technologies.Strong Organic Sales Growth
Organic sales growth exceeded 10% for both Q4 and the full year of 2024, with the U.S. seeing a 10.6% increase and international sales growing by 8.8%.
Successful Product Launches
Successful product launches including the LIFEPAK 35 and Pangea plating system drove strong sales and robust customer interest.
Mako System Expansion
Record quarter and year of installations for the Mako system in the U.S. and worldwide, with increasing utilization in knee and hip procedures.
Acquisition of Inari
Stryker announced the acquisition of Inari, entering the peripheral vascular market with a $15 billion addressable opportunity, supported by Inari's high gross margin profile.
Operating Margin Expansion
Achieved a 200 basis point improvement in Q4 operating margins and a 110 basis point improvement for the full year versus 2023.
---
SYK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SYK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 28, 2025 | $395.15 | $391.07 | -1.03% |
| Oct 29, 2024 | $358.18 | $362.59 | +1.23% |
| Jul 30, 2024 | $328.72 | $325.96 | -0.84% |
| Apr 30, 2024 | $334.19 | $325.86 | -2.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Stryker Corporation (SYK) report earnings?
Stryker Corporation (SYK) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Stryker Corporation (SYK) earnings time?
Stryker Corporation (SYK) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SYK EPS forecast?
SYK EPS forecast for the fiscal quarter 2025 (Q1) is 2.74.
---